Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)”

313 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 313 results

Not applicableUnknownNCT04367350
What this trial is testing

Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement

Who this might be right for
COVIDSars-CoV2Corona Virus Infection+2 more
University Hospital Tuebingen 500
Large-scale testing (Phase 3)Ended earlyNCT04847141
What this trial is testing

Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients

Who this might be right for
COVID-19Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Grifols Therapeutics LLC 465
Large-scale testing (Phase 3)Study completedNCT04510493
What this trial is testing

Canakinumab in Patients With COVID-19 and Type 2 Diabetes

Who this might be right for
Coronavirus InfectionDiabetes Mellitus, Type 2
University Hospital, Basel, Switzerland 116
Testing effectiveness (Phase 2)Study completedNCT04375098
What this trial is testing

Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
Pontificia Universidad Catolica de Chile 58
Not applicableNot Yet RecruitingNCT07813481
What this trial is testing

ELderly REspiratory VIral Cohort

Who this might be right for
Influenza VirusesRespiratory Syncytial Virus (RSV)Severe Acute Respiratory Syndrome Coronavirus 2+5 more
Assistance Publique - Hôpitaux de Paris 1,000
Not applicableNo Longer AvailableNCT04646031
What this trial is testing

Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19

Who this might be right for
Covid19
Tasly Pharmaceuticals, Inc.
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Early research (Phase 1)Study completedNCT04661839
What this trial is testing

A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults

Who this might be right for
COVID-19
Emergent BioSolutions 28
Not applicableStudy completedNCT04391738
What this trial is testing

Association Between BMI and COVID-19

Who this might be right for
SARS-CoV 2
University Hospital, Lille 1,200
Not applicableStudy completedNCT06162533
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria

Who this might be right for
COVID-19
Medical University of Graz 9,090,868
Testing effectiveness (Phase 2)Study completedNCT04521309
What this trial is testing

SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients

Who this might be right for
COVID-19
Dow University of Health Sciences 50
Not applicableStudy completedNCT05236309
What this trial is testing

Investigation on the Epidemic Prevention Effect of Using Chinese Medicine During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak.

Who this might be right for
COVID-19 Pandemic
Taipei City Hospital 2,000
Large-scale testing (Phase 3)Study completedNCT05249816
What this trial is testing

Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Cogna Technology Solutions LLC 1,000
Not applicableStudy completedNCT04725084
What this trial is testing

Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 355
Large-scale testing (Phase 3)Enrolling By InvitationNCT05787418
What this trial is testing

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

Who this might be right for
COVID-19
Huahui Health 1,200
Large-scale testing (Phase 3)UnknownNCT04519125
What this trial is testing

Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2COVID-19
Hospital Universitario San Ignacio 950
Testing effectiveness (Phase 2)Study completedNCT04712110
What this trial is testing

TAK-019 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Takeda 200
Not applicableStudy completedNCT04854408
What this trial is testing

Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns

Who this might be right for
Covid19Vaccine ReactionCoronavirus+2 more
Kanuni Sultan Suleyman Training and Research Hospital 300
Testing effectiveness (Phase 2)Study completedNCT06508320
What this trial is testing

A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)

Who this might be right for
InfluenzaSARS-CoV-2
ModernaTX, Inc. 932
Early research (Phase 1)WithdrawnNCT05155982
What this trial is testing

A Clinical Trial of COVAC-1, a COVID-19 Vaccine, in Generally Healthy Adults

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
University of Saskatchewan
Next Page